论文信息 - Letter to the Editor Regarding "Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia". - 字舞流文

Letter to the Editor Regarding "Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia".

N. Hamad | D. Purtill | R. Blennerhassett

[1] D. Curtis,et al. Variable CD34+ recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic , 2020, Blood advances.

[2] S. Montoto,et al. The challenge of COVID-19 and hematopoietic cell transplantation; EBMT recommendations for management of hematopoietic cell transplant recipients, their donors, and patients undergoing CAR T-cell therapy. , 2020, Bone marrow transplantation.

[3] Kyle M. Hebert,et al. Hematopoietic Cell Transplantation with Cryopreserved Grafts for Severe Aplastic Anemia , 2020, Biology of Blood and Marrow Transplantation.

[4] R. Storb,et al. Severe aplastic anemia: allogeneic bone marrow transplantation as first-line treatment. , 2018, Blood advances.

[5] H. Sengeløv,et al. Current outcome of HLA identical sibling versus unrelated donor transplants in severe aplastic anemia: an EBMT analysis , 2015, Haematologica.